Obesity Management

On the HCPLive Obesity Management condition center page, resources on the topics of medical news and expert insight into clinical weight management can be found. Content includes articles, interviews, videos, podcasts, and breaking news on obesity research, treatment, and drug development.

Latest News

Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths
Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths

September 7th 2024

Semaglutide lowers rates of cardiovascular and COVID-19-related deaths in patients with overweight/obesity, offering promising cardio-metabolic and non-cardiovascular benefits.

Children with Obesity Have Increased Risk of Atopic Dermatitis
Children with Obesity Have Increased Risk of Atopic Dermatitis

August 23rd 2024

HbA1c Highly Predicts NAFLD Disease Severity
HbA1c Highly Predicts NAFLD Disease Severity

August 19th 2024

Heart failure stock imagery. | Credit: Fotolia
Tirzepatide Reduces Heart Failure Outcomes in Obesity-Related Heart Failure

August 1st 2024

Rong Xu, PhD | Credit: Case Western Reserve University
Study Finds Semaglutide Can Reduce Risk of Tobacco-Related Healthcare Use

July 29th 2024

Latest CME Events & Activities

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

October 16, 2024

Register Now!

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

October 26, 2024

Register Now!

6th Annual Advanced Practice Collaborative

View More

SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals

View More

Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

November 18, 2024

Register Now!

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis

View More

Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

View More

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

View More

Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis

View More

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

© 2024 MJH Life Sciences

All rights reserved.